These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27813176)
1. Therapeutic Potential of Small Molecule Inhibitors. Khera N; Rajput S J Cell Biochem; 2017 May; 118(5):959-961. PubMed ID: 27813176 [TBL] [Abstract][Full Text] [Related]
2. A historical overview of protein kinases and their targeted small molecule inhibitors. Roskoski R Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888 [TBL] [Abstract][Full Text] [Related]
3. Harnessing impaired energy metabolism in cancer cell: small molecule- mediated ways to regulate tumorigenesis. Govardhan KS; Ramyasri K; Kethora D; Ravishekar Y; Prasenjit M Anticancer Agents Med Chem; 2011 Mar; 11(3):272-9. PubMed ID: 21434854 [TBL] [Abstract][Full Text] [Related]
4. Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy. Jurj A; Fontana B; Varani G; Calin GA Trends Cancer; 2024 Sep; 10(9):809-824. PubMed ID: 39107162 [TBL] [Abstract][Full Text] [Related]
5. Small-molecule regulators of autophagy and their potential therapeutic applications. Zhou M; Wang R ChemMedChem; 2013 May; 8(5):694-707. PubMed ID: 23568434 [TBL] [Abstract][Full Text] [Related]
6. The emerging role of CXC chemokines and their receptors in cancer. Vinader V; Afarinkia K Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Xia Y; Choi HK; Lee K Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612 [TBL] [Abstract][Full Text] [Related]
8. Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics. Maschinot CA; Pace JR; Hadden MK Curr Med Chem; 2015; 22(35):4033-57. PubMed ID: 26310919 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibitors of autophagy as novel cancer therapeutic agents. Wang C; Hu Q; Shen HM Pharmacol Res; 2016 Mar; 105():164-75. PubMed ID: 26826398 [TBL] [Abstract][Full Text] [Related]
10. Targeting Legumain As a Novel Therapeutic Strategy in Cancers. Mai CW; Chung FF; Leong CO Curr Drug Targets; 2017; 18(11):1259-1268. PubMed ID: 27993111 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer. Hadden MK Curr Med Chem; 2015; 22(35):4031-2. PubMed ID: 26630931 [No Abstract] [Full Text] [Related]
12. Targeting components of epigenome by small molecules. You JS; Han JH Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764 [TBL] [Abstract][Full Text] [Related]
13. Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. Heffron TP J Med Chem; 2016 Nov; 59(22):10030-10066. PubMed ID: 27414067 [TBL] [Abstract][Full Text] [Related]
14. Cellular Senescence-Inducing Small Molecules for Cancer Treatment. Liu P; Lu Z; Wu Y; Shang D; Zhao Z; Shen Y; Zhang Y; Zhu F; Liu H; Tu Z Curr Cancer Drug Targets; 2019; 19(2):109-119. PubMed ID: 29848278 [TBL] [Abstract][Full Text] [Related]
15. Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment. Perrot CY; Javelaud D; Mauviel A Pharmacol Ther; 2013 Feb; 137(2):183-99. PubMed ID: 23063491 [TBL] [Abstract][Full Text] [Related]
16. 25 years of small molecular weight kinase inhibitors: potentials and limitations. Fabbro D Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667 [TBL] [Abstract][Full Text] [Related]
17. Precision oncology-featuring the special issue guest editor "Cancer Letters". Wang H Cancer Lett; 2020 Jul; 482():72-73. PubMed ID: 32200040 [No Abstract] [Full Text] [Related]
18. Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics. Kim DH; Sim T Arch Pharm Res; 2012 Mar; 35(4):605-15. PubMed ID: 22553052 [TBL] [Abstract][Full Text] [Related]
19. Small-molecule PARP modulators--current status and future therapeutic potential. Penning TD Curr Opin Drug Discov Devel; 2010 Sep; 13(5):577-86. PubMed ID: 20812149 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway. Maira SM; Furet P; Stauffer F Future Med Chem; 2009 Apr; 1(1):137-55. PubMed ID: 21426073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]